Last reviewed · How we verify
NCT05566730
Culturally Tailored Cannabis Use Disorder App
NA trial testing CT-MICART App in Cannabis Use in 50 participants. Completed in 31 January 2024.
17 November 2023
Quick facts
| Lead sponsor | University of Houston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 14 June 2023 |
| Primary completion | 17 November 2023 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CT-MICART App
- Control
Conditions studied
- Cannabis Use — all drugs for Cannabis Use →
Sponsor
University of Houston
Who can join
18 and older, any sex, with Cannabis Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aims to address disparities in cannabis use outcomes among African American/Black (hereby referred to as Black) adults with cannabis use disorder (CUD). The specific aims of this study are: (1) to develop a culturally adapted, mobile app for Black cannabis users (CT-MICART) using knowledge from the current research team, published literature, expert opinion, and feedback from the Community Research Advisory Board (CRAB), (2) to pilot test CT-MICART and (3) focus on analysis of data collected as part of Aim 2.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial.
Nizio P, Clausen B, Businelle MS, Ponton N, et al · · 2024 · PMID 38373037 · DOI 10.2196/52776
Verify or expand the search:
- PubMed search for NCT05566730
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cannabis Use
Currently open trials in the same condition.
- NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
- NCT07168707 — Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study · NA · recruiting
- NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
- NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
- NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting
Other University of Houston trials
Trials by the same sponsor.
- NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
- NCT07025772 — Shaping Habitual Impulses For a Tobacco-free Style · NA · recruiting
- NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
- NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
- NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05566730 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Houston
- Last refreshed: 7 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05566730.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing